Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › Aethlon Medical › JANE STREET GROUP, LLC now owns 5% of AEMD as a passive investor Fund moves
Why it stands out A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Oct 6, 2026
Reporting period Not applicable
Filed with the SEC Oct 13, 2026 passive 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0001595888-26-000121
Data quality Verified: identifiers matched exactly
Around the same time Insider filing
Traded Sep 30 · filed 15 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Sep 30 · filed 15 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Apr 17 · filed 181 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Aug 13, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors Sep 11, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On September 11, 2026, Aethlon Medical, Inc. (the “Company”) entered into amendments to the employment agreements of James B. Frakes, the Company’s Chief Executive Officer and Chief Financial Officer, and Steven P. LaRosa, M.D., the Company’s Chief Medical Officer (collectively, the “Amendments”).” Sep 17, 2026 Company filing · Form 8-K · Material agreement, Change of control Control of the company changed hands, and signed an important agreement (and 1 more item) “On September 17, 2026, the Company and North Immunology issued a joint press release announcing the entry into the Merger Agreement. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference, except that the information contained on the websites referenced in the press release is not incorporated herein by reference.” Oct 1, 2026 Company filing · Form 8-K · Executive change, Shareholder vote Changed a top executive or board member, and held a shareholder vote “Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.” What came next Oct 7, 2026 Company filing · Form 8-K · Bylaws or charter Changed its bylaws, charter or fiscal year Oct 13, 2026 5% stake JANE STREET GROUP, LLC reported a passive stake (13G) of 5.0% Nov 12, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors